Enliven Therapeutics, Inc. Common Stock
ELVN •
Buy Open
Signal type
Buy
Status
Open
Open Price
$36.73
Stop Loss
$33.96
Performance
22.12%
Days Open
21
Signal Setup
Signal Type Buy
Status Open
Open Date Mar 25, 2026
Open Price $36.73
Stop Loss $33.96
Timespan Day
Company Profile
Name Enliven Therapeutics, Inc. Common Stock
Ticker ELVN
Market Cap $1.22B
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $44.85
List Date Feb 24, 2023
Description
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
Website Open Company Website